EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of Intravenous Immunoglobulins in Pediatric Viral Meningoencephalitis: A Real-World Retrospective Observational Study

Ilaria Lazzareschi, Mariachiara Mercuri iD, Ludovica Renzelli iD, Chiara Veredice iD, Marco Piastra, Anna Camporesi iD, Giulia Bersani, Cristina De Rose, Francesco Proli, Laura Martino, Andrea De Angelis, Rosa Morello und 4 weitere

Journal of Clinical Medicine · 22.05.2026 · 15 (11) · 4024

DOI: 10.3390/jcm15114024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.05.2026. Verfasst von Ilaria Lazzareschi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Area Pediatrica, Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, 00168 Roma, Italy. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Viral meningoencephalitis is a frequent cause of acute central nervous system infection in children, particularly in neonates and young infants. Although etiological diagnosis has improved through molecular testing, management remains largely supportive, and intravenous immunoglobulins (IVIGs) are occasionally used in clinical practice despite limited supporting evidence.

Methods

We performed a single-center retrospective observational study including pediatric patients aged 0–10 years admitted between 2016 and 2025 with molecularly confirmed viral meningoencephalitis. Demographic, clinical, microbiological, therapeutic, and follow-up data were collected. Neurological outcomes and length of hospital stay were compared between patients treated with IVIG and those who were not.

Results

Twenty-nine patients were included. Enterovirus was the most frequently identified pathogen (50.0%), followed by human herpesvirus (35.7%) and human parechovirus (14.3%). IVIG was administered to 28% of patients, all with enterovirus infection. IVIG-treated patients were significantly younger at presentation and more frequently presented with apnea (42.9% vs. 0%, p = 0.014). Most patients had a favorable neurological outcome (85.7%). Unfavorable outcomes, including neurodevelopmental delay and/or epilepsy, occurred in a minority of cases (14.3%) and exclusively in enterovirus-infected patients. No significant association was found between IVIG administration and neurological outcome.

Conclusions

In this real-world pediatric cohort, IVIG use was associated with more severe clinical features rather than improved neurological outcomes, underscoring the need for careful consideration and further investigation in this setting, particularly in the subgroup of infants with enterovirus encephalitis.

Schlagwörter

Stichwörter der Autor:innen

IVIGchildrenencephalitisviral

Autor:innen und Institutionen

  • Area Pediatrica, Dipartimento di Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.
  • Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.
  • Child Neurology and Psychiatry Unit, Department of Neuroscience, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • Paediatric Intensive Care Unit and Trauma Centre, Policlinico Gemelli IRCCS, 00168 Rome, Italy.
  • Division of Pediatric Anesthesia and Intensive Care, ASST Grande Ospedale Metropolitano Milano, 20162 Milano, Italy.

ORCID-Profile: Mariachiara Mercuri, Ludovica Renzelli, Chiara Veredice, Anna Camporesi, Roberta Onesimo, Danilo Buonsenso

Zitieren

APA

Lazzareschi, I., Mercuri, M., Renzelli, L., Veredice, C., Piastra, M., Camporesi, A., Bersani, G., De Rose, C., Proli, F., Martino, L., De Angelis, A., Morello, R., Fiori, B., Santangelo, R., Onesimo, R., & Buonsenso, D. (2026). Use of Intravenous Immunoglobulins in Pediatric Viral Meningoencephalitis: A Real-World Retrospective Observational Study. Journal of Clinical Medicine, 15(11), 4024. https://doi.org/10.3390/jcm15114024

Vancouver

Lazzareschi I, Mercuri M, Renzelli L, Veredice C, Piastra M, Camporesi A, et al. Use of Intravenous Immunoglobulins in Pediatric Viral Meningoencephalitis: A Real-World Retrospective Observational Study. Journal of Clinical Medicine. 2026;15(11):4024. doi:10.3390/jcm15114024

BibTeX
@article{Lazzareschi2026,
  author = {Lazzareschi, Ilaria and Mercuri, Mariachiara and Renzelli, Ludovica and Veredice, Chiara and Piastra, Marco and Camporesi, Anna and Bersani, Giulia and De Rose, Cristina and Proli, Francesco and Martino, Laura and De Angelis, Andrea and Morello, Rosa and Fiori, Barbara and Santangelo, Rosaria and Onesimo, Roberta and Buonsenso, Danilo},
  title = {Use of Intravenous Immunoglobulins in Pediatric Viral Meningoencephalitis: A Real-World Retrospective Observational Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4024},
  doi = {10.3390/jcm15114024}
}
Kostenlos starten →